via Indiana University School of Medicine
For people with diabetes who are insulin dependent, glycemic control is a full-time job. But what if their medication could do the work for them—an insulin whose activity in the bloodstream responds to the blood glucose levels and adjusts accordingly?
An invention from Indiana University School of Medicine Distinguished Professor Michael A. Weiss, MD, PhD, could lead to just that.
In a breakthrough study published in the peer-reviewed journal PNAS, Weiss and his team describe the use of a synthetic “switch” that can be opened or closed using a simple sugar sensor. The study was in part collaborative with Thermalin, Inc., a small biotech company that Weiss began in 2008.
Their concept exploits a natural mechanism, designated the “protective hinge,” that is built into vertebrate insulins. The protective hinge is a natural structural feature that evolved more than half a billion years ago to keep the hormone stable in its closed state but foldable and functional in its open state.
“The reason a glucose-responsive insulin is important is that the biggest barrier to the effective use of insulin, especially in Type 1 diabetes, is the fear of the consequences of blood sugar going too low,” said Weiss, who is also the Chair of the Department of Biochemistry and Molecular Biology.
Immediate consequences of severely low blood sugar (hypoglycemia) can include delirium, convulsions or loss of consciousness, and repeated episodes of severe hypoglycemia can cause cognitive decline. On the other hand, chronic high blood sugar (hyperglycemia) can lead to blindness, stroke or amputation. Staying in the desired blood glucose range is a delicate balance that insulin-dependent diabetics face every day.
But Weiss said that he envisions a future when people do not have to choose to risk their long-term health to protect themselves from the immediate dangers of severe hypoglycemia.
“The promise of this kind of ‘smart’ insulin is that it would transform diabetes care, so people wouldn’t have to worry anymore,” said Weiss. “With our invention, we envision that when the blood sugar goes low, the hinge would close. But there will be much work to do to translate our proof of principle to an FDA-approved product.”
In the 100 years since the discovery of insulin, its use as a treatment for diabetes has gone through many significant changes. C. Ronald Kahn, MD, chief academic officer at the Joslin Diabetes Center at Harvard Medical School, said that glucose-responsive insulin could be the next.
“In the recent study from the Weiss laboratory appearing in PNAS, we see an example of the next exciting phase of insulin development, namely development of an insulin analogue which through chemical modification can sense the level of sugar present in the blood,” said Kahn. “While the current analogue has been designed to sense fructose, it seems likely that this same approach can be used to develop analogues to sense glucose. Whether these can be sensitive enough to be modulated by changes within the physiological range remains to be determined, but if so, this would be an important new tool in the management of diabetes.”
Other types of glucose-responsive insulins are being developed elsewhere. What makes Weiss’ invention unique is its simplicity. The synthetic hinge exploits naturally occurring processes and introduces fewer external or artificial elements compared to other approaches.
While their study uses fructose as model (representative of a monosaccharide like glucose), it proves that Weiss’ synthetic hinge concept works. His team is already working on glucose-responsive insulin candidates that open and close at the desired high and low glucose thresholds, which are respectively 70 to 180 milligrams per deciliter. By replacing the fructose sensor with glucose sensors, a revolutionary insulin therapy may be closer than we think.
Original Article: Synthetic hinge could hold key to revolutionary “smart” insulin therapy
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Diabetes in East Asia
As of 2021, around 537 million adults between the ages of 20 and 79 are living with diabetes worldwide. This number is expected to reach 643 million by 2030 and 783 million by 2045. According to the ...
- Another step toward an insulin tablet
For the millions of people living with diabetes, insulin is a life-saving drug. Unlike many other medicines, though, insulin cannot be easily delivered by swallowing a pill -- it needs to be injected ...
- The Biggest Myth About Starting Type 2 Diabetes Drugs
People have the misconception that taking glucose-lowering medication is a sign of weakness or that it means you are very sick. Early treatment, however, may be the key to keeping you healthier over ...
- Sevoflurane may increase intraoperative blood sugar levels in non-diabetic adults undergoing neurosurgery
Intraoperative use of desflurane and sevoflurane in non-diabetic, ASA I and II patients undergoing neurosurgery demonstrated a change in blood sugar pattern in a new study published in the Indian ...
- Doctors Say These are the Signs of Type 1 Diabetes, Including Fatigue
Chances are you or someone you know has diabetes. The American Diabetes Association states, "In 2019, 37.3 million Americans, or 11.3% of the population, had diabetes. Nearly 1.9 million Americans ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”glucose-responsive insulin” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
- With 4.8% CAGR, Diabetes Care Devices Market to Hit US$ 42,119.3 million by 2028 – Exclusive Research by The Insight Partners
The presentations illustrated increases in Time in Range when using an InPen smart insulin pen, safety of an extended-wear infusion set that lasts up to 7 days, and patient satisfaction with the ...
- Doctors: In future, diabetics to take once-a-week smart insulin
This will soon become a thing of the past. The future insulin will be glucose sensitive and ‘smart’. It will understand the patient’s need and release the exact amount of insulin the patient ...
- Smart Insulin Pen Market Size 2023 with New Report by Prominent Players & Peak Selling Price till 2029
Jan 04, 2023 (The Expresswire) -- "Smart Insulin Pen Market" New Research Insights Report 2023 | [ The Smart Insulin Pen market has witnessed a growth ...
- Smart Insulin Pen Market 2023-2028 : Leading Growth Drivers, Emerging Audience, Segments, Industry Sales, Profits & Analysis
Final Report will add the analysis of the impact of Russia-Ukraine War and COVID-19 on this industry. This research ...
- Smart Diabetes Management Market will surpass USD 20.66 billion by 2030 : GreyViews
The Product segment is smart glucose meter, smart insulin pens, smart insulin pumps, continuous blood glucose monitoring system, and apps. The continuous blood glucose monitoring system ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”smart insulin” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]